Measurement and prediction of lateral diffusion within human sclera

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 7, 2006, Pages 3011-3016

  Jiang, Jason ^a,b   Geroski, Dayle H ^a   Edelhauser, Henry F ^a   Prausnitz, Mark R ^b  

^a EMORY EYE CENTER   (United States)

^b Georgia Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULFORHODAMINE B; FLUORESCENT DYE; TEXAS RED; XANTHENE DERIVATIVE;

ARTICLE; DIFFUSION; HUMAN; MATHEMATICAL MODEL; PERMEABILITY; PREDICTION; PRIORITY JOURNAL; RETINA IMAGE; SCLERA; MATHEMATICS; METABOLISM; SPECTROFLUOROMETRY; THEORETICAL MODEL; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; FLUORESCENT DYES; HUMANS; MATHEMATICS; MODELS, THEORETICAL; SCLERA; SPECTROMETRY, FLUORESCENCE; XANTHENES;

EID: 33746675802     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1464     Document Type: Article

References (17)

1. Lang JC. Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev. 1995;16:39-43.
2. Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci. 2000;41:961-964.
3. Tasman W. Duane's Foundations of Clinical Ophthalmology. Philadelphia: Lippincott-Raven; 1995.
4. Maurice D. Review: practical issues in intravitreal drug delivery. J Ocul Pharmacol Ther. 2001;17:393-401.
5. Olsen TW, Aaberg SY, Geroski DH, Edelhauser HF. Human sclera: thickness and surface area. Am J Ophthalmol. 1998;125:237-241.
6. Maurice DM, Polgar J. Diffusion across the sclera. Exp Eye Res. 1977;25:577-582.
7. Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human scleral permeability: effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Vis Sci. 1995;36:1893-1903.
8. Prausnitz MR, Edwards A, Noonan JS, Rudnick DE, Edelhauser HF, Geroski DH. Measurement and prediction of transient transport across sclera for drug delivery to the eye. Ind Eng Chem Res. 1998;37:2903-2907.
9. Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41:1181-1185.
10. Cruysberg LP, Nuijts RM, Geroski DH, Koole LH, Hendrikse F, Edelhauser HF. In vitro human scleral permeability of fluorescein, dexamethasone- fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system. J Ocul Pharmacol Ther. 2002;18:559-569.
11. Gilbert JA, Simpson AE, Rudnick DE, Geroski DH, Aaberg TM Jr, Edelhauser HF. Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix. J Control Release. 2003;89:409-417.
12. Mora P, Eperon S, Felt-Baeyens O, et al. Trans-scleral diffusion of triamcinolone acetonide. Curr Eye Res. 2005;30:355-361.
13. Fatt I, Weissman BA. Physiology of the Eye: An Introduction to the Vegetative Functions. Boston: Butterworth-Heinemann; 1992.
14. Rudnick DE, Noonan JS, Geroski DH, Prausnitz MR, Edelhauser HF. The effect of intraocular pressure on human and rabbit scleral permeability. Invest Ophthalmol Vis Sci. 1999;40:3054-3058.
15. Edwards A, Prausnitz MR. Fiber matrix model of sclera and corneal stroma for drug delivery to the eye. AIChE J. 1998;44:214-225.
16. Cussler EL. Diffusion: Mass Transfer in Fluid Systems. Cambridge, UK: Cambridge University Press; 1997.
17. Prausnitz MR, Noonan JS. Permeability of cornea, sclera and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479-1488.